|
|
| | 3′,5′-diOA-dC Basic information |
| | 3′,5′-diOA-dC Chemical Properties |
| solubility | Ethanol: 10 mg/ml |
| | 3′,5′-diOA-dC Usage And Synthesis |
| Description | 3′,5′-diOA-dC is a ligand for the bacterial second messenger, cyclic dinucleotide, and STING agonist cyclic di-GMP (Item No. 17144) composed of oleic acid (Item Nos. 90260 | 24659) and deoxycytidine.1 It assembles with cyclic di-GMP to form supramolecular nanoparticles and has been used to deliver cyclic di-GMP in vitro and in vivo. Intravenous administration of nanoparticles composed of 3′,5′-diOA-dC and cyclic di-GMP decrease tumor weight and volume, increase the number of CD8+ T cells, neutrophils, and natural killer (NK) cells in the tumor microenvironment, and increase tumoral levels of TNF-α and IFN-γ in a B16/F10 murine melanoma model.WARNING This product is not for human or veterinary use. | | References | [1] LI XU, XINYUAN ZHU* Supramolecular Cyclic Dinucleotide Nanoparticles for STING-Mediated Cancer Immunotherapy[J]. ACS Nano, 2023, 17 11: 10090-10103. DOI: 10.1021/acsnano.2c12685 |
| | 3′,5′-diOA-dC Preparation Products And Raw materials |
|